Why Wound Care Advocacy Matters
Wound care advocacy matters because patient access depends on more than clinical care alone. It is shaped by Medicare policy, reimbursement, coverage rules, and providers' ability to deliver evidence-based treatment. The Wound and Hyperbaric Association (WHA) focuses on improving access to quality wound and hyperbaric care through advocacy and collaboration.
Why Advocacy Is So Important in Wound Care
Chronic wounds affect millions of Americans and create a substantial burden for the healthcare system. Research published in Advances in Wound Care estimated thatchronic nonhealing wounds affect about 8.2 million Medicare beneficiaries. When the burden is this large, policy and payment decisions can have a major effect on access, treatment patterns, and outcomes.
That is why advocacy matters. In wound care, policy directly influences patient care. Coverage and reimbursement rules determine access to advanced therapies and how quickly patients receive proper interventions.
Why Wound Care Advocacy Matters Right Now
This issue is especially important right now due to ongoing changes in Medicare policy on skin substitutes and cellular, acellular, and matrix-like products (CAMPs). In April 2025, CMS announced a review of coverage policies for certain skin-substitute products and postponed the effective date of related final Local Coverage Determinations (LCDs) to January 1, 2026. CMS made this delay because it considered ongoing patient access to be important during the review. Following this, CMS released additional updates that are tied to the 2026 Medicare physician payment policy.
How Medicare Policy Affects Access to Wound Care
For providers, organizations, and patients, Medicare policy changes can directly affect what care is available in practice. CMS issues Local Coverage Determinations that define specific rules for wound care and the application of skin substitutes. These policies shape the reimbursement systems for advanced wound treatments, affecting whether and how care is delivered.
When payment and coverage policies shift, the impact can extend beyond billing. They can influence care planning, treatment availability, and adoption of advanced therapies. That is why specialty advocacy matters: It helps ensure that policy discussions reflect clinical realities, evidence, and patient needs rather than administrative simplification alone.
Why WHA’s Role Matters
WHA’s role matters because wound care advocacy requires a unified voice. Our mission is to bring together patients, clinicians, institutions, and industry stakeholders to improve access to high-quality, evidence-based wound and hyperbaric care. In a policy environment shaped by reimbursement updates, LCDs, and evolving expectations for evidence, such coalition-based advocacy is important.
Advocacy is not only about responding to policy changes after they happen. It is also about helping shape better ones by bringing together evidence, clinical experience, and practical recommendations. That makes advocacy one of the most important tools in protecting patient access and supporting the future of wound care. This conclusion is an inference supported by WHA’s mission and its recent policy-focused content.
The Future of Wound Care Depends on Advocacy
As debates over Medicare coverage, reimbursement, and access continue to evolve, advocacy will remain central to the future of wound care. Patients need access to appropriate, evidence-based treatment. Providers need policies that reflect the realities of care delivery. And the field needs strong organizations that can credibly speak to both clinical quality and patient access.
That is why wound care advocacy is essential now.
Take action now. Join WHA’s advocacy efforts to make your voice heard. Help shape wound care policy to protect patient access and support providers. Engage with WHA today and ensure a positive future for wound care.
References
Centers for Medicare & Medicaid Services. (2025, April 11). CMS statement on Local Coverage Determination for certain skin substitute grafts. CMS Newsroom.
Centers for Medicare & Medicaid Services. (2025, December 24). Final Local Coverage Determinations (LCDs) for certain skin substitutes. CMS Fact Sheet.
Centers for Medicare & Medicaid Services. LCD: Application of bioengineered skin substitutes to lower extremity chronic non-healing wounds (L35041). Medicare Coverage Database.
Sen, C. K. (2019). Human wounds and its burden: An updated compendium of estimates. Advances in Wound Care.
